-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Meeting News
-
Special Plenary to Focus on IASLC’s Role in Shaping Thoracic Cancer Research, Treatment
Former IASLC CEO Dr. Paul A. Bunn, Jr., says lung cancer is a global challenge and the unique multinational and multi-specialty nature of the IASLC has helped to build a global response.
-
Learn and Network During Poster Viewing Events
The WCLC 2024 program includes several opportunities to browse posters and see the latest in thoracic oncology research.
-
First Presidential Symposium to Explore Practice-Changing Research in Lung Cancer Screening, Immune Oncology
The session will also include late-breaking data from HARMONi-2, NeoCOAST-2, and TROPION-Lung01 as well as an address from IASLC President Dr. Paul Van Schil.
-
Action Needed to Improve Gender Equity in Thoracic Oncology
While women remain a minority in thoracic oncology, Drs. Narjust Florez and Linda Martin say change is happening. The duo will co-chair a special session designed to address issues faced by women in the field.
-
IASLC President-Elect Reflects on Importance of Prevention, Screening, Biomarker Testing and More
Dr. Caicun Zhou discusses his plans for WCLC 2024 as well as his goals for his time as IASLC President.
-
Empowering Change and Amplifying Impact Through Research Advocacy Activities
In a Q&A with ILCN, patient advocate Isaac Joseph discusses the importance of patient advocacy in resource-limited settings.
-
Meet the Expert: Digital Health for Supportive Care Delivery
Palliative care expert Dr. Jennifer Temel talks about the role of digital health apps in supportive care interventions during an interview with ILCN.
-
2024 Distinguished Service Award Recipients Honored During Opening Plenary Session
Drs. Kwun Fong, Claudia Henschke, Erik Thunnissen, and Julie Brahmer were recognized for their pioneering efforts in the field of thoracic oncology.
-
Welcome to San Diego and the 2024 World Conference on Lung Cancer
As WCLC 24 gets under way, IASLC CEO Dr. Karen Kelly discusses the association’s 50th birthday, meeting highlights, and more during an interview with ILCN.
-
Joint IASLC-CSCO-CAALC Session to Explore Global Scope of Lung Cancer Prevention, Evidence-Based Medicine
IASLC President-elect Caicun Zhou, MD, PhD, and CAALC Chair Chunxue Bai, MD, PhD, say the session provides an opportunity for colleagues from around the world to exchange ideas and learn from regional and cultural differences.